Reversal of Methamphetamine Induced Cognitive Deficits and mGlu Receptors
逆转甲基苯丙胺引起的认知缺陷和 mGlu 受体
基本信息
- 批准号:8077331
- 负责人:
- 金额:$ 1.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2011-07-15
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAgonistAmphetaminesAnimal ModelAreaAttenuatedBehaviorBrainChronicCocaineCognitiveCognitive deficitsCorpus striatum structureCuesDorsalDoseDrug Delivery SystemsDrug usageGlutamatesGoalsHippocampus (Brain)HumanImpaired cognitionImpairmentInjection of therapeutic agentIntakeIntravenousLaboratoriesMemoryMemory impairmentMetabotropic Glutamate ReceptorsMethamphetamineMethamphetamine dependenceModelingNeuronsNucleus AccumbensPathologyPerformancePharmaceutical PreparationsPharmacotherapyPhasePrefrontal CortexPublic HealthRattusReceptor ActivationReportingResearchReversal LearningSalineSelf AdministrationTestingTherapeutic InterventionTimecognitive functionexperienceinsightlearning extinctionmeetingsmemory recognitionmetabotropic glutamate receptor 2methamphetamine abuseneuromechanismneurotoxicitynovelobject recognitionpre-clinicalpsychostimulantpublic health relevancereceptorreceptor expressionresearch studytranslational approach
项目摘要
DESCRIPTION (provided by applicant):
Project Summary Meth-induced cognitive impairments observed in addicts after chronic drug use comprise a particularly serious problem in meth addiction and treatment. As such, there is a need for research efforts to develop animal models with translational relevance to the cognitive impairments observed in human meth addiction. Preclinical animal models reveal long-lasting impairments in recognition memory in rats. Specifically, high dose non-contingent meth injections can produce neurotoxicity and disrupt performance on memory tasks. Most object recognition studies have used short term, non-contingent drug delivery approaches to study the impact of meth on recognition memory. Intravenous meth self-administration offers a translational approach as a model of human meth addiction and the impact of chronic meth on cognitive function. The preliminary research shows that contingent long-access meth causes deficits in recognition memory, and that meth intake correlates with this memory deficit 24 hrs later. One purpose of this proposal is to determine whether these deficits in recognition memory involve a glutamatergic mechanism. In order to reverse meth-induced deficits in recognition memory, Specific Aim 1 will use a metabotropic glutamate receptor (mGluR) 2/3 agonist during acquisition of novel object recognition and Specific Aim 2 will use a mGluR5 positive allosteric modulator. Additionally, the experiments in this proposal will identify meth-induced changes in mGluR 2/3 and 5 expression in brain areas related to meth addiction (i.e., nucleus accumbens, dorsal striatum, and prefrontal cortex) and recognition memory (i.e., perirhinal cortex and hippocampus) following abstinence from long- access daily meth. Meth intake, object recognition scores, and receptor levels will be examined for correlations and predictive relationships. Identifying such relationships will provide new insights into meth- induced cognitive deficits, elucidate underlying neuronal mechanisms, and help identify possible therapeutic interventions in this animal model.
PUBLIC HEALTH RELEVANCE:
Project Narrative The overall purpose of these studies is to determine the relationships between motivated meth-taking behavior over time, meth-induced cognitive impairments, and the underlying neural mechanisms. The use of a translational animal model of meth addiction allows for the study of cognitive and motivational deficits that are manifested in meth addiction. Additionally, identification of neural mechanisms involved with this translational model may help identify promising new pharmacotherapeutic targets for meth-induced cognitive deficits.
描述(由申请人提供):
项目摘要 长期吸毒后在成瘾者中观察到的冰毒引起的认知障碍是冰毒成瘾和治疗中一个特别严重的问题。因此,需要进行研究工作来开发与人类冰毒成瘾中观察到的认知障碍具有转化相关性的动物模型。临床前动物模型揭示了大鼠认知记忆的长期损害。具体来说,高剂量的非偶然冰毒注射会产生神经毒性并扰乱记忆任务的表现。大多数物体识别研究都使用短期、非偶然的药物输送方法来研究冰毒对识别记忆的影响。静脉注射冰毒自我给药提供了一种转化方法,作为人类冰毒成瘾模型以及慢性冰毒对认知功能的影响。初步研究表明,长期服用冰毒会导致识别记忆缺陷,而冰毒摄入量与 24 小时后的记忆缺陷相关。该提案的一个目的是确定这些识别记忆缺陷是否涉及谷氨酸能机制。为了扭转冰毒引起的识别记忆缺陷,Specific Aim 1 将在获得新物体识别过程中使用代谢型谷氨酸受体 (mGluR) 2/3 激动剂,Specific Aim 2 将使用 mGluR5 正变构调节剂。此外,本提案中的实验将确定在戒除长期服用冰毒后,与冰毒成瘾(即伏核、背侧纹状体和前额皮质)和识别记忆(即鼻周皮层和海马)相关的大脑区域中冰毒引起的 mGluR 2/3 和 5 表达的变化。将检查冰毒摄入量、物体识别分数和受体水平的相关性和预测关系。确定这种关系将为了解冰毒引起的认知缺陷提供新的见解,阐明潜在的神经元机制,并帮助确定该动物模型中可能的治疗干预措施。
公共卫生相关性:
项目叙述这些研究的总体目的是确定随着时间的推移,动机性吸食冰毒行为、冰毒引起的认知障碍和潜在的神经机制之间的关系。使用冰毒成瘾的转化动物模型可以研究冰毒成瘾中表现的认知和动机缺陷。此外,识别与这种转化模型相关的神经机制可能有助于确定治疗冰毒引起的认知缺陷的有希望的新药物治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carmela M Reichel其他文献
ACNP 59th Annual Meeting: Poster Session I
ACNP 第 59 届年会:海报会议 I
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:7.6
- 作者:
Jordan Carter;Angela M. Kearns;Anna Kruyer;Jordan L. Hopkins;Peter Kalivas;Carmela M Reichel;Wan;Melissa A. Brotman - 通讯作者:
Melissa A. Brotman
Carmela M Reichel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carmela M Reichel', 18)}}的其他基金
Measuring in Vivo Meth-induced Neurovascular Changes Using Quantitative MRI
使用定量 MRI 测量体内冰毒引起的神经血管变化
- 批准号:
8426291 - 财政年份:2013
- 资助金额:
$ 1.53万 - 项目类别:
Corticostriatal Neuroplasticity and Cognition in Methamphetamine Addiction
甲基苯丙胺成瘾中的皮质纹状体神经可塑性和认知
- 批准号:
8847307 - 财政年份:2012
- 资助金额:
$ 1.53万 - 项目类别:
Cortical Plasticity in Methamphetamine Addiction
甲基苯丙胺成瘾的皮质可塑性
- 批准号:
10197063 - 财政年份:2012
- 资助金额:
$ 1.53万 - 项目类别:
Corticostriatal Neuroplasticity and Cognition in Methamphetamine Addiction
甲基苯丙胺成瘾中的皮质纹状体神经可塑性和认知
- 批准号:
8661731 - 财政年份:2012
- 资助金额:
$ 1.53万 - 项目类别:
Corticostriatal Neuroplasticity and Cognition in Methamphetamine Addiction
甲基苯丙胺成瘾中的皮质纹状体神经可塑性和认知
- 批准号:
8544462 - 财政年份:2012
- 资助金额:
$ 1.53万 - 项目类别:
Reversal of Methamphetamine Induced Cognitive Deficits and mGlu Receptors
逆转甲基苯丙胺引起的认知缺陷和 mGlu 受体
- 批准号:
7908133 - 财政年份:2010
- 资助金额:
$ 1.53万 - 项目类别:
Competition Between Conditioned Rewards: Novelty vs. Cocaine
有条件奖励之间的竞争:新奇与可卡因
- 批准号:
7269132 - 财政年份:2007
- 资助金额:
$ 1.53万 - 项目类别:
Competition Between Conditioned Rewards: Novelty vs. Cocaine
有条件奖励之间的竞争:新奇与可卡因
- 批准号:
7425310 - 财政年份:2007
- 资助金额:
$ 1.53万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 1.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 1.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 1.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)